Kalytera Announces Grant of Stock Options

Updated: Jun 8, 2018

Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (KALTF) (the “Company” or “Kalytera”) today announced that it has granted stock options on January 30, 2018 to certain directors and officers of the Company. The stock options have an exercise price of $0.38 per common share and expire ten years from the date of grant. 


Subscribe for News and Insights

© 2021 All Rights Reserved. Katan Associates International.

  • LinkedIn - Grey Circle